AI for RNA Biomarker Discovery and Drug Development with Rafael Rosengarten | VibeCast Episode 41

In this episode, VibeCast host Ray Dogum speaks with Rafael Rosengarten, PhD, CEO of Genialis, about biomarker discovery and drug development.

--------------------------------------------------------------------------------------------
The key moments in this episode are:
00:00:33 - Exploring Raphael's Background and Journey
00:04:50 - Favorite Guest on "Talking Precision Medicine"
00:07:02 - Joining Genialis as a Co-founder
00:10:18 - Genialis' Mission in Precision Medicine
00:12:04 - Evolution of Cancer and Predictive Biomarker Space
00:14:17 - Importance of AI in Biomarker Discovery
00:17:29 - Risks and Challenges in AI Drug Discovery
00:19:59 - Genialis's Competitive Advantage in AI Drug Discovery
00:22:48 - Genialis's Funding Journey
00:24:42 - Introduction to Responder ID
00:25:26 - Building a Supermodel
00:27:14 - Strategic Partnerships
00:28:34 - Setting Genialis Apart
00:31:36 - Genialis' Vision

Guest Bio:
Rafael leads Genialis’ effort to realize the promise of precision medicine, and to build a company that puts people first as a guiding principle. Prior to Genialis, he spent nearly 20 years in biomedical research, publishing on the evolution of innate immune systems, bioengineering of microbes, and genetics of development. Rafael co-invented the j5 DNA assembly design automation software for high-throughput molecular design and analyses (since commercialized by TeselaGen). Rafael earned his doctorate at Yale University, and conducted his postdoctoral research at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI) and Baylor College of Medicine. In his free time, Rafael enjoys beaches and mountains, coffee and kettlebells, and exploring the world with his wife and two children.

Guest Links:
Linkedin: https://www.linkedin.com/in/rrosengarten/
Genialis Linkedin: https://www.linkedin.com/company/genialis/
Genialis Website: https://www.genialis.com/

About VibeCast
VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation.

Guests include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.

Follow Vibe Bio's Socials:
https://twitter.com/VibeBio
https://www.linkedin.com/company/vibe-bio/
https://www.instagram.com/vibebiotechnology/
https://www.tiktok.com/@vibebio
https://www.facebook.com/VibeBiotechnology/

Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.